These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15634597)

  • 21. Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells.
    Lu M; Wang J; Li Y; Berenzon D; Wang X; Mascarenhas J; Xu M; Hoffman R
    Blood; 2010 Nov; 116(20):4284-7. PubMed ID: 20625010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
    Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells.
    Konopleva M; Zhao S; Hu W; Jiang S; Snell V; Weidner D; Jackson CE; Zhang X; Champlin R; Estey E; Reed JC; Andreeff M
    Br J Haematol; 2002 Aug; 118(2):521-34. PubMed ID: 12139741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
    Passamonti F; Vanelli L; Malabarba L; Rumi E; Pungolino E; Malcovati L; Pascutto C; Morra E; Lazzarino M; Cazzola M
    Haematologica; 2003 Oct; 88(10):1123-9. PubMed ID: 14555308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
    Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
    Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
    J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl-2 and Bcl-x expression in the CD34+ cells of aplastic anaemia patients: relationship with increased apoptosis and upregulation of Fas antigen.
    Ismail M; Gibson FM; Gordon-Smith EC; Rutherford TR
    Br J Haematol; 2001 Jun; 113(3):706-12. PubMed ID: 11380462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A probable role for trail-induced apoptosis in the pathogenesis of marrow failure. Implications from an in vitro model and from marrow of aplastic anemia patients.
    Kakagianni T; Giannakoulas NC; Thanopoulou E; Galani A; Michalopoulou S; Kouraklis-Symeonidis A; Zoumbos NC
    Leuk Res; 2006 Jun; 30(6):713-21. PubMed ID: 16310248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impaired apoptosis of peripheral blood CD4+T cells in patients with rheumatoid arthritis].
    Cao Y; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):682-5, 688. PubMed ID: 25940298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric analysis of the expression of Fas/Fasl in bone marrow CD34+ cells in myelodysplastic syndromes: relation to disease progression.
    Ribeiro E; Lima CS; Metze K; Lorand-Metze I
    Leuk Lymphoma; 2004 Feb; 45(2):309-13. PubMed ID: 15101716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice.
    Ishii T; Zhao Y; Sozer S; Shi J; Zhang W; Hoffman R; Xu M
    Exp Hematol; 2007 Nov; 35(11):1633-40. PubMed ID: 17764815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
    Oppliger Leibundgut E; Brunold C; Marti D; Horn MP; Seiler C; Schroeder V; Schmid JP; Tobler A; Zwicky C
    Haematologica; 2005 Jul; 90(7):875-80. PubMed ID: 15996924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34- bone marrow cell compartments from patients with myelodysplastic syndromes.
    Suárez L; Vidriales MB; Sanz G; López A; López-Berges MC; de Santiago M; Palomera L; Bernal T; Pérez de Equiza ME; San Miguel JF; Orfao A
    Leukemia; 2004 Jul; 18(7):1311-3. PubMed ID: 15116120
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of interferon on the expressions of TRAIL and other apoptosis- inducing genes in peripheral blood mononuclear cells from polycythemia rubra vera].
    Liu YF; Chen SM; Sun H
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):323-6. PubMed ID: 16875583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the imprinted tumour-suppressor gene H19 is tightly regulated during normal haematopoiesis and is reduced in haematopoietic precursors of patients with the myeloproliferative disease polycythaemia vera.
    Núnêz C; Bashein AM; Brunet CL; Hoyland JA; Freemont AJ; Buckle AM; Murphy C; Cross MA; Lucas G; Bostock VJ; Brady G
    J Pathol; 2000 Jan; 190(1):61-8. PubMed ID: 10640993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of DAPT on biological activity of hematopoietic stem cells in mice].
    Zhang N; Zhang LY; Zhang Y; Ji Q; Wang JH; Qi RZ; Xu J; Yuan WP; Cheng T; Gao YD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):679-85. PubMed ID: 22739182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes.
    Berger G; Hunault-Berger M; Rachieru P; Fontenay-Roupie M; Baranger L; Ifrah N; Zandecki M
    Hematol J; 2001; 2(2):87-96. PubMed ID: 11424000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera.
    Steidl U; Schroeder T; Steidl C; Kobbe G; Graef T; Bork S; Pechtel S; Kliszewski S; Kuendgen A; Rohr UP; Fenk R; Schroeder M; Haase D; Haas R; Kronenwett R
    Ann N Y Acad Sci; 2005 Jun; 1044():94-108. PubMed ID: 15958702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.